Shenzhen Yilifang biotechnology Co., ltd.
Detection of genetic diseases, detection of infectious diseases of the respiratory tract, detection of tumor early or prognosis, detection of karyotype analysis

Yilifang Biotech.
Shenzhen Yilifang Biotechnology Co.,‍εδ Ltd. was establishe §d in 2013. It is a nati∑ ∏onal high-tech enterprise integrating t∞ he development, producλ≥₹tion and sales of prec✔™₽ision medical in vitro diagnostic ←α✔÷ reagents. The companychr←∞↕(34)s research and development tea★εm consist of scientific researchers from top ★™'σinternational institutions and domestic translati↔♠♣<on medical elites, including high-quality talent  s of national leading talents, Class B peacocαδ‌≥k talents, and reserve talents. Targetinδ₩™βg existing "pain points" in the market, Yilifang↑ ✘ links with domestic and foreign cutting-​↓δedge technologies and≥•☆ committed to creating good products that c× ≤₩an truly address the demands ∑←¶≠form the market.

Product architecture
From the major diseases th↔α at the society needs to solve urgently,‌α Yilifang has built prod≤☆ucts in four major sectors. It has s✔®uccessfully developed more→★ than 20 Class III in vitro diagnostic prod ←ucts, and its products have α"↑gradually entered the national registrati§™on stage.

Yilifang was established in the✘‍≈ new era of precision medicine. Since its  ‌♣inception, Yilifang has been pragmatic and prudeε↕αnt in its work style. It has vigor£γ ±ously coordinated dev®♠<elopment in talent cultivation, '₽research and development innovation, safety compπ™δliance, and quality system constr♠→uction, etc. It has also made initial achieve∑&​ments. In terms of talent training, a✘<£§ high-quality elite team has been created. ₩★<$Among the current members, about 50% of employ¥÷€ ees have masterchr(34)s ♦→↔↑degrees, and more than 10% have doctoral degree‍♦s. A platform, a post-doctoral practice anεΩ" d innovation base, for sustainably§₽ meeting the needs of high-end talents-a postd→>♥✘octoral practice innov∏₽←ation base has been esta ±™blished. On the other hand,¶ '¶ Yilifang adheres to the idea of quality as •≤™¶the basis and regulations a‍ €★s the norm, and has establish​♣ed a comprehensive system in terms of q≥≈→Ωuality and safety, fire safety £∑±and environmental protection. In terms of techn≤♠✘¥ological innovation, Yilifang has obtainφΩed national, provincial, and muni♠•✘§cipal department’ recognition→Ω ✔ and awards at various levels£β∑ through independent research and d₹∏¶∑evelopment. In 2017, as the only representδδ‌ative of the Shenzhen In vitro D↓§±iagnostic Reagent Ente<∏rprise Group, it was promotedβ>δγ to the National Innovation and Entrepre>↑neurship Competition.

  • 7
  • 8
  • 9
  • 10
  • 11
  • 12